Prospective pertussis surveillance in Switzerland, 1991-2006

Vaccine

Volumn 29, Issue 11, 2011, Pages 2058-2065

  Wymann, Monica N ^a   Richard, Jean Luc ^a   Vidondo, Beatriz ^a   Heininger, Ulrich ^b  

^a FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Age distribution; Pertussis; Sentinel surveillance system; Switzerland; Vaccination status

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BORDETELLA PERTUSSIS; BRONCHITIS; CHILD; CONTROLLED STUDY; COUGHING; EPIDEMIC; GENERAL PRACTITIONER; GROUPS BY AGE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFECTION; MAJOR CLINICAL STUDY; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PEDIATRICIAN; PERTUSSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIB FRACTURE; SCHOOL CHILD; SWITZERLAND; VACCINATION; VOMITING;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; HUMANS; INCIDENCE; INFANT; PERTUSSIS VACCINE; SENTINEL SURVEILLANCE; SWITZERLAND; WHOOPING COUGH; YOUNG ADULT;

EID: 79951814409     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.017     Document Type: Article

References (29)

1. Bundesamt für Gesundheit, Eidgenössische Kommission für Impffragen (EKIF). Schweizerischer Impfplan 2010. Richtlinien und Empfehlungen. Bern: Bundesamt für Gesundheit, 2010. Available at: Accessed 5 January, 2011. http://www.ekif.ch/.
2. Matter H.C., Cloetta J., Zimmermann H., Sentinella-Arbeitsgemeinschaft Das Meldesystem Sentinella in der Schweiz am Beispiel des Pertussismonitorings von 1991 bis 1993. Schweiz Rundschau für Medizin (PRAXIS) 1995, 84:690-697.
3. WHO-recommended surveillance standard of Pertussis. Available at: Accessed 5 January, 2011. http://www.who.int/immunization_monitoring/diseases/pertussis_surveillance/en/index.html.
4. Schläpfer G., Cherry J.D., Heininger U., Überall M., Schmitt-Grohé S., Laussucq S., et al. Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr Infect Dis J 1995, 14:209-214.
5. Houard S., Hackel C., Herzog A., Bollen A. Specific identification of Bordetella pertussis by the polymerase chain reaction. Res Microbiol 1989, 140:477-487.
6. Celentano L.P., Massari M., Paramatti D., Salmaso S., Tozzi A.E. EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005, 24:761-765.
7. Carlsson R.M., Trollfors B. Control of Pertussis - lessons learnt from a 10-year surveillance programme in Sweden. Vaccine 2009, 27:5709-5718.
8. Fabiánová K., Benes C., Kríz B. A steady rise in incidence of pertussis since nineties in the Czech Republic. Epidemiol Mikrobiol Imunol 2010, 59:25-33.
9. Hellenbrand W., Beier D., Jensen E., Littmann M., Meyer C., Oppermann H., et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009, 9:22.
10. Tozzi A.E., Pandolfi E., Celentano L.P., Massari M., Salmaso S., Ciofi degli Atti M.L. Comparison of pertussis surveillance systems in Europe. Vaccine 2007, 25:291-297.
11. de Greeff S.C., de Melker H.E., van Gageldonk P.G., Schellekens J.F., van der Klis F.R., Mollema L., et al. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 2010, 5(12):e14183.
12. Duclos P. Pertussis, parapertussis (whooping cough). Control of communicable diseases manual 2004, 399-404. American Public Health Association, Washington. 18th ed. D.L. Heymann (Ed.).
13. Matter H.C., Schmidt-Schlapfer G., Zimmermann H., Sentinella-Arbeitsgemeinschaft Erfassung einer Keuchhustenepidemie 1994/95 in der Schweiz durch das Sentinella-Meldesystem. Schweiz Med Wochenschr 1996, 126:1423-1431.
14. EUVAC.Net. Available at: Accessed 5 January 2011. http://www.euvac.net/graphics/euvac/trends_pertussis.html.
15. Bundesamt für Gesundheit Durchimpfung in der Schweiz 2005-2007. Bull BAG 2010, 11:367-377.
16. Anderson R.M., May R.M. Modern vaccines. Immunisation and herd immunity. The Lancet 1990, 335:641-645.
17. Wendelboe A.M., van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005, 24:58-61.
18. Cherry J.D. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005, 115:1422-1427.
19. Heininger U. Pertussis: an old disease that is still with us. Curr Opin Infect Dis 2001, 14:329-335.
20. Heininger U., Stehr K., Cherry J.D. Serious pertussis overlooked in infants. Eur J Pediatr 1992, 151:342-343.
21. Crowcroft N.S., Andrews N., Rooney C., Brisson M., Miller E. Deaths from pertussis are underestimated in England. Arch Dis Child 2002, 86:336-338.
22. Heininger U., Stehr K., Schmidt-Schläpfer G., Penning R., Vock R., Kleemann W.J., et al. Bordetella pertussis infections and sudden unexpected deaths in children. Eur J Pediatr 1996, 155:551-553.
23. Lindgren C., Milerad J., Lagercrantz H. Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur J Pediatr 1997, 156:405-409.
24. Ghanaie R.M., Karimi A., Sadeghi H., Esteghamti A., Falah F., Armin S., et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis 2010, 14:e1072-e1075.
25. Centers for Diseases Control and Prevention Pertussis. Epidemiology and prevention of vaccine-preventable diseases 2009, 199-216. Public Health Foundation, Washington, DC. 11th ed. W. Atkinson, S. Wolfe, J. Hamborsky, L. McIntyre (Eds.).
26. Bonmarin I., Levy-Bruhl D., Baron S., Guiso N., Njamkepo E., Caro V. Pertussis surveillance in French hospitals: results from a 10 year period. Eurosurveillance 2007, 12:1-8.
27. Centers for Diseases Control Prevention Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR 2006, 55(RR03):1-34.
28. Van Buynder P.G., Owen D., Vurdien J.E., Andrews N.J., Matthews R.C., Miller E. Bordetella pertussis surveillance in England and Wales: 1995-1997. Epidemiol Infect 1999, 123:403-411.
29. Heininger U., Cherry J.D. Pertussis immunisation in adolescents and adults - Bordetella pertussis epidemiology should guide vaccination recommendations. Expert Opin Biol Ther 2006, 6:685-697.